Exacerbation of Atopic Dermatitis in a Patient Treated With Infliximab

Statistics

Cases and Research Letters

Exacerbación de dermatitis atópica en paciente tratado con infliximab

R. Ruiz-Villaverde

Corresponding author

ismenios@hotmail.com

Corresponding author.

, M. Galán-Gutierrez

Unidad de Dermatología, Complejo Hospitalario de Jaén, Jaén, Spain

Read

9375

Times
was read the article

2584

Total PDF

6791

Total HTML

Share statistics

Article information

ISSN: 15782190
Original language: English

DOI:10.1016/j.adengl.2012.09.001

The statistics are updated each day

Year/Month	Html	Pdf	Total

2025 6	22	9	31
2025 5	186	46	232
2025 4	187	30	217
2025 3	155	28	183
2025 2	171	26	197
2025 1	121	41	162
2024 12	103	20	123
2024 11	110	59	169
2024 10	98	37	135
2024 9	96	21	117
2024 8	137	51	188
2024 7	118	40	158
2024 6	119	32	151
2024 5	88	33	121
2024 4	76	37	113
2024 3	113	30	143
2024 2	79	31	110
2024 1	68	40	108
2023 12	85	24	109
2023 11	75	17	92
2023 10	79	17	96
2023 9	95	27	122
2023 8	75	22	97
2023 7	92	38	130
2023 6	69	30	99
2023 5	80	28	108
2023 4	72	26	98
2023 3	72	21	93
2023 2	65	22	87
2023 1	48	25	73
2022 12	66	45	111
2022 11	40	30	70
2022 10	25	18	43
2022 9	31	45	76
2022 8	32	31	63
2022 7	33	37	70
2022 6	23	20	43
2022 5	76	27	103
2022 4	104	27	131
2022 3	63	47	110
2022 2	57	17	74
2022 1	60	36	96
2021 12	55	41	96
2021 11	62	43	105
2021 10	72	47	119
2021 9	64	51	115
2021 8	66	29	95
2021 7	71	25	96
2021 6	65	22	87
2021 5	57	42	99
2021 4	74	55	129
2021 3	39	25	64
2021 2	57	22	79
2021 1	33	13	46
2020 12	34	15	49
2020 11	29	19	48
2020 10	20	16	36
2020 9	42	14	56
2020 8	26	20	46
2020 7	33	18	51
2020 6	47	30	77
2020 5	35	14	49
2020 4	32	19	51
2020 3	30	26	56
2020 2	3	8	11
2020 1	4	2	6
2019 12	6	2	8
2019 11	4	0	4
2019 10	0	1	1
2019 8	4	5	9
2019 7	4	6	10
2019 6	4	7	11
2019 5	4	14	18
2019 4	2	12	14
2019 3	2	8	10
2019 2	0	5	5
2019 1	2	0	2
2018 12	2	0	2
2018 11	2	0	2
2018 10	3	0	3
2018 9	3	0	3
2018 5	0	5	5
2018 3	4	2	6
2018 2	34	4	38
2018 1	45	13	58
2017 12	47	8	55
2017 11	41	5	46
2017 10	58	3	61
2017 9	39	9	48
2017 8	45	11	56
2017 7	31	6	37
2017 6	50	7	57
2017 5	38	12	50
2017 4	38	24	62
2017 3	45	27	72
2017 2	35	6	41
2017 1	30	13	43
2016 12	47	8	55
2016 11	43	19	62
2016 10	66	11	77
2016 9	56	5	61
2016 8	40	7	47
2016 7	32	17	49
2016 6	6	0	6
2016 5	9	14	23
2016 4	3	1	4
2016 3	6	0	6
2016 2	13	2	15
2016 1	4	4	8
2015 12	7	0	7
2015 11	21	6	27
2015 10	10	6	16
2015 9	16	1	17
2015 8	13	2	15
2015 7	60	9	69
2015 6	35	6	41
2015 5	83	12	95
2015 4	77	14	91
2015 3	43	4	47
2015 2	54	13	67
2015 1	69	20	89
2014 12	59	14	73
2014 11	42	13	55
2014 10	58	23	81
2014 9	34	7	41
2014 8	21	8	29
2014 7	21	6	27
2014 6	33	4	37
2014 5	42	8	50
2014 4	32	2	34
2014 3	45	11	56
2014 2	31	18	49
2014 1	37	14	51
2013 12	32	8	40
2013 11	21	15	36
2013 10	11	3	14
2013 9	16	5	21
2013 8	14	12	26
2013 7	15	33	48
2013 6	12	23	35
2013 5	14	11	25
2013 4	22	15	37
2013 3	17	6	23
2013 2	41	4	45
2013 1	37	5	42
2012 12	27	9	36
2012 11	7	6	13
2012 10	1	1	2

Show all

Indexed in:

Follow us:

Statistics

Indexed in:

Follow us:

Statistics

Subscribe to our newsletter